Onderzoeksoutput per jaar
Onderzoeksoutput per jaar
Onderzoeksoutput
- 11 resultaten
Zoekresultaten
-
2023
An AAV-mediated liver-directed gene therapy metabolically corrects alkaptonuria in an Hgd deficient mouse model
Lequeue, S., Norman, B. P., Neuckermans, J., Colemonts-Vroninks, H., Hughes, J. H., Claes, P., Heymans, A., Ranganath, L., Gallagher, J., Vanhaecke, T., Bou-Gharios, G. & De Kock, J., 14 aug 2023.Onderzoeksoutput: Poster
Open Access -
Development of a robust high-throughput screenings system for the evaluation of tyrosine ammonia lyases in the context of inborn errors of tyrosine metabolism
Nulmans, I., Laga, C. A., Salvi, N. S., Desmet, L., Lequeue, S., Neuckermans, J. & De Kock, J., 19 sep 2023.Onderzoeksoutput: Poster
-
2022
Development of a robust high-throughput screening system for the evaluation of human homogentisate 1,2-dioxygenase missense variants in the context of rare disease alkaptonuria
Lequeue, S., Neuckermans, J., Vanhaecke, T. & De Kock, J., 2022.Onderzoeksoutput: Poster
-
Development of a robust high-throughput screening system to evaluate single nucleotide polymorphisms of human homogentisate 1,2-dioxygenase in the context of rare disease alkaptonuria
Lequeue, S., Neuckermans, J., Vanhaecke, T. & De Kock, J., 14 nov 2022.Onderzoeksoutput: Poster
Open Access -
2020
Directed protein evolution as a tool to innovate gene therapy for hereditary tyrosinemia type 1
Neuckermans, J., Colemonts-Vroninks, H., Marcélis, L., Mertens, A., Schwaneberg, U. & De Kock, J., mrt 2020.Onderzoeksoutput: Poster
-
Impact of nitisinone treatment and discontinuation on the metabolome of wildtype and hereditary tyrosinemia type 1 mice
Colemonts-Vroninks, H., Norman, B., Davison, A., Neuckermans, J., Marcélis, L., Mortier, A., De Bundel, D., Ranganath, L., Martens, G., Vanhaecke, T., Gallagher, J. & De Kock, J., 17 apr 2020, blz. FRI284.Onderzoeksoutput: Poster
-
2019
Evaluation of the efficiency of CRE mRNA-induced recombination in human skin-derived mesenchymal stem cells
Rombaut, M., Colemonts-Vroninks, H., Neuckermans, J., Boeckmans, J., van Grunsven, L. A., Vanhaecke, T. & De Kock, J., 21 nov 2019.Onderzoeksoutput: Poster
-
2018
Development of a high-throughput bacterial inhibition assay for human 4-hydroxyphenylpyruvate dioxygenase in the context of tyrosinemia type 1
Neuckermans, J., 2018, (Unpublished).Onderzoeksoutput: Poster
-
Human skin-derived mesenchymal stromal cells do not rescue hereditary tyrosinemia type 1 mice after permanent nitisinone withdrawal
Colemonts-Vroninks, H., Laeremans, H., Claes, P., Neuckermans, J., Verhulst, S., van Grunsven, L. A., Martens, G., De Bundel, D., Vanhaecke, T. & De Kock, J., sep 2018, blz. S37-S219.Onderzoeksoutput: Poster
-
2017
ESTABLISHMENT OF THE OPTIMAL MRNA ELECTROPORATION PROTOCOL FOR HUMAN SKIN-DERIVED MESENCHYMAL STEM CELLS
Neuckermans, J., Branson, S., Heirman, C., Vanhaecke, T., Rogiers, V. & De Kock, J., 28 mrt 2017, (Unpublished).Onderzoeksoutput: Poster
-
Establishment of the optimal mRNA electroporation protocol for human skin-derived mesenchymal stem cells.
Neuckermans, J., Branson, S., Vanhaecke, T. & De Kock, J., 2017.Onderzoeksoutput: Poster